P-wave dispersion and left atrial volume index as predictors in heart failure

Rose Mary Ferreira Lisboa da Silva1, Nadya Mendes Kazzaz, Rosália Morais Torres

  • 1Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil. roselisboa@uol.com.br

Insights

P-wave dispersion (PWD) did not predict cardiovascular events (CE) in heart failure (HF) patients. However, left atrial volume index (LAVi) independently predicted CE, with Chagas disease patients experiencing worse outcomes.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Background:

  • P-wave dispersion (PWD) and left atrial volume index (LAVi) are established predictors of cardiovascular events (CE).
  • Assessing these markers is crucial for risk stratification in heart failure (HF) patients.

Purpose of the Study:

  • To determine the prognostic significance of PWD and LAVi for CE occurrence in stable heart failure patients.
  • To evaluate the predictive value of these indices in a prospective cohort.

Main Methods:

  • A longitudinal prospective study included 78 stable heart failure patients (mean age 47.2 years, 52% male).
  • Patients underwent clinical evaluation, electrocardiogram (ECG), and echocardiogram assessments.
  • Follow-up duration was 26.5 months to monitor for cardiovascular events.

Main Results:

  • Left atrial volume index (LAVi > 28 mL/m²) was identified as an independent predictor of CE (p=0.02).
  • Patients with LAVi > 28 mL/m² had a significantly higher risk of events (Odds Ratio 14.4, p=0.00).
  • Chagas disease etiology was also associated with worse outcomes (Odds Ratio 3.2, p=0.03), while PWD showed no correlation with CE.

Conclusions:

  • Left atrial volume index (LAVi) is a significant independent predictor of cardiovascular events in heart failure patients.
  • P-wave dispersion (PWD) does not appear to be a reliable predictor of CE in this population.
  • Chagasic heart disease patients face a poorer prognosis, highlighting the need for tailored management strategies.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...